2024年6月，东软集团发布讣告，宣布公司高级副总裁陈宏印先生因突发疾病，经全力抢救无效，于2024年6月19日不幸逝世，享年58岁。陈宏印自1996年加入东软以来，长期从事医疗信息化、健康科技及企业战略管理工作，在推动东软医疗业务发展、构建智慧医疗生态体系方面作出了重要贡献。他历任东软医疗CEO、东软集团高级副总裁等职务，是公司核心管理层的重要成员之一。东软集团在公告中对陈宏印的离世表示沉痛哀悼，并向其家属致以深切慰问。公司强调，目前经营一切正常，各项业务有序推进。陈宏印的突然离世不仅令东软内部深感震惊与悲痛，也在国内IT与医疗科技行业引发广泛关注。他的专业精神、战略视野和对健康产业的深刻理解，被业界广泛认可。东软表示将继承其遗志，继续深耕医疗健康与数字技术融合的创新之路。
In June 2024, Neusoft Corporation announced the passing of Mr. Chen Hongyin, Senior Vice President of the company, who died suddenly from an acute illness on June 19, 2024, at the age of 58, despite intensive medical efforts. Mr. Chen joined Neusoft in 1996 and had long been dedicated to healthcare IT, health technology, and corporate strategy. He played a pivotal role in advancing Neusoft’s healthcare business and building its smart healthcare ecosystem. Over his career, he served as CEO of Neusoft Medical and later as Senior Vice President of Neusoft Group, becoming a key member of the company’s executive leadership. Neusoft expressed profound grief over his unexpected death and extended heartfelt condolences to his family. The company confirmed that its operations remain stable and all business activities are proceeding as planned. Mr. Chen’s sudden passing has deeply shocked Neusoft and drawn significant attention across China’s IT and health tech sectors. Widely respected for his professionalism, strategic vision, and deep understanding of the healthcare industry, his legacy will continue to inspire Neusoft’s ongoing commitment to innovation at the intersection of digital technology and healthcare.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/2344.html